Kudoh T, Ishidate T, Moriyama M, Toyoshima K, Akiyama T
Department of Oncogene Research, Osaka University, Japan.
Proc Natl Acad Sci U S A. 1995 May 9;92(10):4517-21. doi: 10.1073/pnas.92.10.4517.
WT1, the Wilms tumor-suppressor gene, maps to the human chromosomal region 11p13 and encodes a transcriptional repressor, WT1, implicated in controlling normal urogenital development. Microinjection of the WT1 cDNA into quiescent cells or cells in early to mid G1 phase blocked serum-induced cell cycle progression into S phase. The activity of WT1 varied significantly depending on the presence or absence of an alternatively spliced region located upstream of the zinc finger domain. The inhibitory activity of WT1 was abrogated by the overexpression of cyclin E/CDK2 as well as cyclin D1/CDK4. Furthermore, both CDK4- and CDK2-associated kinase activities were downregulated in cells overexpressing WT1, whereas the levels of CDK4, CDK2, and cyclin D1 expression were unchanged. These findings suggest that inhibition of the activity of cyclin/CDK complexes may be involved in mediating the WT1-induced cell cycle block.
WT1是一种威尔姆斯肿瘤抑制基因,定位于人类染色体区域11p13,编码一种转录抑制因子WT1,参与调控正常泌尿生殖系统发育。将WT1互补DNA显微注射到静止细胞或处于G1期早期至中期的细胞中,可阻断血清诱导的细胞周期进入S期。WT1的活性因锌指结构域上游一个可变剪接区域的存在与否而有显著差异。细胞周期蛋白E/细胞周期蛋白依赖性激酶2(cyclin E/CDK2)以及细胞周期蛋白D1/细胞周期蛋白依赖性激酶4(cyclin D1/CDK4)的过表达可消除WT1的抑制活性。此外,在过表达WT1的细胞中,与CDK4和CDK2相关的激酶活性均下调,而CDK4、CDK2和细胞周期蛋白D1的表达水平未发生变化。这些发现表明,细胞周期蛋白/细胞周期蛋白依赖性激酶(cyclin/CDK)复合物活性的抑制可能参与介导WT1诱导的细胞周期阻滞。